Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

The future of risk communication and the role of the pharmaceutical industry.

Chakraborty S, Bouder F.

Curr Drug Saf. 2013 Feb;8(1):4-10.

PMID:
23656442
2.

Risk Communication and the Pharmaceutical Industry: what is the reality?

Edwards B, Chakraborty S.

Drug Saf. 2012 Nov 1;35(11):1027-40. doi: 10.2165/11635220-000000000-00000.

PMID:
23061779
3.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
4.

The US drug safety system: role of the pharmaceutical industry.

Gibson BR, Suh R, Tilson H.

Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):110-4.

PMID:
17724741
5.

The World Health Organization and the Pharmaceutical Industry. Common areas of interest and differing views.

Hardwicke CJ.

Adverse Drug React Toxicol Rev. 2002;21(1-2):51-99. Review.

PMID:
12140907
6.

Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.

Gaspar R, Aksu B, Cuine A, Danhof M, Takac MJ, Linden HH, Link A, Muchitsch EM, Wilson CG, Ohrngren P, Dencker L.

Eur J Pharm Sci. 2012 Dec 18;47(5):979-87. doi: 10.1016/j.ejps.2012.09.020. Epub 2012 Oct 6.

PMID:
23046836
7.

Early communication of drug safety concerns: a feasibility study on enhancing interaction between the pharmaceutical industry and regulators.

Swain E, Morgan S, Brewster W, Kauser S.

Pharmacoepidemiol Drug Saf. 2010 Mar;19(3):232-7. doi: 10.1002/pds.1898.

PMID:
20033909
8.

Consumer trust in food safety--a multidisciplinary approach and empirical evidence from Taiwan.

Chen MF.

Risk Anal. 2008 Dec;28(6):1553-69. doi: 10.1111/j.1539-6924.2008.01115.x. Epub 2008 Sep 11.

PMID:
18793284
9.

Guidelines, editors, pharma and the biological paradigm shift.

Singh AR, Singh SA.

Mens Sana Monogr. 2007 Jan;5(1):27-30. doi: 10.4103/0973-1229.32176.

10.

[Psychiatrists and the pharmaceutical industry].

Helmchen H.

Nervenarzt. 2003 Nov;74(11):955-64. German.

PMID:
14694885
11.

The role of healthcare communications agencies in maintaining compliance when working with the pharmaceutical industry and healthcare professionals.

Cairns A, Yarker YE.

Curr Med Res Opin. 2008 May;24(5):1371-8. doi: 10.1185/030079908X297367 . Epub 2008 Apr 1.

PMID:
18384708
12.

Braving a faceless new world? Conceptualizing trust in the pharmaceutical industry and its products.

Brown P, Calnan M.

Health (London). 2012 Jan;16(1):57-75. doi: 10.1177/1363459309360783. Epub 2010 Dec 15.

PMID:
21169205
13.

Health literacy knowledge among direct-to-consumer pharmaceutical advertising professionals.

Mackert M.

Health Commun. 2011 Sep;26(6):525-33. doi: 10.1080/10410236.2011.556084. Epub 2011 Jun 24.

PMID:
21469006
14.

Melding regulatory, pharmaceutical industry, and U.S. payer perspectives on improving approaches to heterogeneity of treatment effect in research and practice.

Willke RJ, Crown W, Del Aguila M, Cziraky MJ, Khan ZM, Migliori R.

Value Health. 2013 Sep-Oct;16(6 Suppl):S10-5. doi: 10.1016/j.jval.2013.06.006.

15.

The importance of news media in pharmaceutical risk communication: proceedings of a workshop.

Mebane FE.

Pharmacoepidemiol Drug Saf. 2005 May;14(5):297-306.

PMID:
15386695
16.

Reputation, relationships, risk communication, and the role of trust in the prevention and control of communicable disease: a review.

Cairns G, de Andrade M, MacDonald L.

J Health Commun. 2013;18(12):1550-65. doi: 10.1080/10810730.2013.840696. Review.

PMID:
24298887
17.

Guiding principles of safety as a basis for developing a pharmaceutical safety culture.

Edwards B, Olsen AK, Whalen MD, Gold MJ.

Curr Drug Saf. 2007 May;2(2):135-9. Review.

PMID:
18690959
18.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
19.

The effect of risk communication on risk perceptions: the significance of individual differences.

Gerrard M, Gibbons FX, Reis-Bergan M.

J Natl Cancer Inst Monogr. 1999;(25):94-100. Review.

PMID:
10854464
20.

Future societal issues in industrial biotechnology.

Schuurbiers D, Osseweijer P, Kinderlerer J.

Biotechnol J. 2007 Sep;2(9):1112-20. Review.

PMID:
17639531

Supplemental Content

Support Center